Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

Cited In for PubMed (Select 20421463)

1.

RNA Viruses and RNAi: Quasispecies Implications for Viral Escape.

Presloid JB, Novella IS.

Viruses. 2015 Jun 19;7(6):3226-40. doi: 10.3390/v7062768. Review.

2.

Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model.

Ispas G, Koul A, Verbeeck J, Sheehan J, Sanders-Beer B, Roymans D, Andries K, Rouan MC, De Jonghe S, Bonfanti JF, Vanstockem M, Simmen K, Verloes R.

PLoS One. 2015 May 26;10(5):e0126959. doi: 10.1371/journal.pone.0126959. eCollection 2015.

3.

Inactivated E. coli transformed with plasmids that produce dsRNA against infectious salmon anemia virus hemagglutinin show antiviral activity when added to infected ASK cells.

García K, Ramírez-Araya S, Díaz Á, Reyes-Cerpa S, Espejo RT, Higuera G, Romero J.

Front Microbiol. 2015 Apr 16;6:300. doi: 10.3389/fmicb.2015.00300. eCollection 2015.

4.
5.

Development of small RNA delivery systems for lung cancer therapy.

Fujita Y, Kuwano K, Ochiya T.

Int J Mol Sci. 2015 Mar 6;16(3):5254-70. doi: 10.3390/ijms16035254. Review.

6.

Identification of metabolically stable 5'-phosphate analogs that support single-stranded siRNA activity.

Prakash TP, Lima WF, Murray HM, Li W, Kinberger GA, Chappell AE, Gaus H, Seth PP, Bhat B, Crooke ST, Swayze EE.

Nucleic Acids Res. 2015 Mar 31;43(6):2993-3011. doi: 10.1093/nar/gkv162. Epub 2015 Mar 9.

7.

Challenges and opportunities in developing respiratory syncytial virus therapeutics.

Simões EA, DeVincenzo JP, Boeckh M, Bont L, Crowe JE Jr, Griffiths P, Hayden FG, Hodinka RL, Smyth RL, Spencer K, Thirstrup S, Walsh EE, Whitley RJ.

J Infect Dis. 2015 Mar 15;211 Suppl 1:S1-S20. doi: 10.1093/infdis/jiu828.

8.

Mechanism of action for respiratory syncytial virus inhibitor RSV604.

Challa S, Scott AD, Yuzhakov O, Zhou Y, Tiong-Yip CL, Gao N, Thresher J, Yu Q.

Antimicrob Agents Chemother. 2015 Feb;59(2):1080-7. doi: 10.1128/AAC.04119-14. Epub 2014 Dec 1.

PMID:
25451060
9.

Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Chemaly RF, Shah DP, Boeckh MJ.

Clin Infect Dis. 2014 Nov 15;59 Suppl 5:S344-51. doi: 10.1093/cid/ciu623. Review.

PMID:
25352629
10.

The potential for a controlled human infection platform in Singapore.

Balasingam S, Horby P, Wilder-Smith A.

Singapore Med J. 2014 Sep;55(9):456-61.

11.

Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives.

Torrecilla J, Rodríguez-Gascón A, Solinís MÁ, del Pozo-Rodríguez A.

Biomed Res Int. 2014;2014:161794. doi: 10.1155/2014/161794. Epub 2014 Aug 12. Review.

12.

Platelet Activating Factor Receptor Activation Improves siRNA Uptake and RNAi Responses in Well-differentiated Airway Epithelia.

Krishnamurthy S, Behlke MA, Apicella MA, McCray PB Jr, Davidson BL.

Mol Ther Nucleic Acids. 2014 Jul 15;3:e175. doi: 10.1038/mtna.2014.26.

13.

Small interfering RNA inhibition of Andes virus replication.

Chiang CF, Albariňo CG, Lo MK, Spiropoulou CF.

PLoS One. 2014 Jun 12;9(6):e99764. doi: 10.1371/journal.pone.0099764. eCollection 2014.

14.

siRNA delivery to the lung: what's new?

Merkel OM, Rubinstein I, Kissel T.

Adv Drug Deliv Rev. 2014 Aug;75:112-28. doi: 10.1016/j.addr.2014.05.018. Epub 2014 Jun 5. Review.

PMID:
24907426
15.

The new world of RNAs.

Dogini DB, Pascoal VD, Avansini SH, Vieira AS, Pereira TC, Lopes-Cendes I.

Genet Mol Biol. 2014 Mar;37(1 Suppl):285-93. Review.

16.

Medical applications of RNA interference (RNAi).

Pereira TC, Lopes-Cendes I.

BMC Proc. 2013 Apr 4;7 Suppl 2:K21. doi: 10.1186/1753-6561-7-S2-K21. eCollection 2013. No abstract available.

17.

Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in mice.

Zafra MP, Mazzeo C, Gámez C, Rodriguez Marco A, de Zulueta A, Sanz V, Bilbao I, Ruiz-Cabello J, Zubeldia JM, del Pozo V.

PLoS One. 2014 Mar 17;9(3):e91996. doi: 10.1371/journal.pone.0091996. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105924.

18.

Soluble leukocyte-Associated Ig-like Receptor-1 in amniotic fluid is of fetal origin and positively associates with lung compliance.

Houben ML, Olde Nordkamp MJ, Nikkels PG, van der Ent CK, Meyaard L, Bont L.

PLoS One. 2013 Dec 26;8(12):e83920. doi: 10.1371/journal.pone.0083920. eCollection 2013.

19.

Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.

Bawage SS, Tiwari PM, Pillai S, Dennis V, Singh SR.

Adv Virol. 2013;2013:595768. doi: 10.1155/2013/595768. Epub 2013 Dec 9. Review.

20.

RNAi Therapeutic Platforms for Lung Diseases.

Fujita Y, Takeshita F, Kuwano K, Ochiya T.

Pharmaceuticals (Basel). 2013 Feb 6;6(2):223-50. doi: 10.3390/ph6020223.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk